Literature DB >> 15964276

Generation of cloned mice by direct nuclear transfer from natural killer T cells.

Kimiko Inoue1, Hiroshi Wakao, Narumi Ogonuki, Hiromi Miki, Ken-ichiro Seino, Rika Nambu-Wakao, Shinichi Noda, Hiroyuki Miyoshi, Haruhiko Koseki, Masaru Taniguchi, Atsuo Ogura.   

Abstract

Cloning mammals by nuclear transfer (NT) remains inefficient. One fundamental question is whether clones have really been derived from differentiated cells rather than from rare stem cells present in donor-cell samples. To date, cells, such as mature lymphocytes, with genetic differentiation markers have been cloned to generate mice only via a two-step NT involving embryonic stem (ES) cell generation and tetraploid complementation [1, 2 and 3]. Here, we show that the genome of a unique T-cell population, natural killer T (NKT) cells, can be fully reprogrammed by a single-step NT. The pups and their placentas possessed the rearranged TCR loci specific for NKT cells. The NKT-cell-cloned embryos had a high developmental potential in vitro: Most (71%) developed to the morula/blastocyst stage, in marked contrast to embryos from peripheral blood T cells (12%; p < 1 x 10(-25)). Furthermore, ES cell lines were efficiently established from these NKT-cell blastocysts. These findings clearly indicate a high level of plasticity in the NKT-cell genome. Thus, differentiation of the genome is not always a barrier to NT cloning for either reproductive or therapeutic purposes, so we can now postulate that at least some mammals cloned to date have indeed been derived from differentiated donor cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964276     DOI: 10.1016/j.cub.2005.05.021

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  36 in total

Review 1.  Programming and reprogramming neuronal subtypes in the central nervous system.

Authors:  Caroline Rouaux; Salman Bhai; Paola Arlotta
Journal:  Dev Neurobiol       Date:  2012-07       Impact factor: 3.964

Review 2.  Induced pluripotency: history, mechanisms, and applications.

Authors:  Matthias Stadtfeld; Konrad Hochedlinger
Journal:  Genes Dev       Date:  2010-10-15       Impact factor: 11.361

Review 3.  Induced pluripotency as a potential path towards iNKT cell-mediated cancer immunotherapy.

Authors:  Hiroshi Watarai; Daisuke Yamada; Shin-ichiro Fujii; Masaru Taniguchi; Haruhiko Koseki
Journal:  Int J Hematol       Date:  2012-05-17       Impact factor: 2.490

Review 4.  Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.

Authors:  Rudolf Jaenisch; Richard Young
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

Review 5.  Epigenetic reprogramming and induced pluripotency.

Authors:  Konrad Hochedlinger; Kathrin Plath
Journal:  Development       Date:  2009-02       Impact factor: 6.868

Review 6.  Cell fusion for reprogramming pluripotency: toward elimination of the pluripotent genome.

Authors:  Danièle Pralong; Alan O Trounson; Paul J Verma
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 7.  Nuclear transfer to eggs and oocytes.

Authors:  J B Gurdon; Ian Wilmut
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

Review 8.  Mediators of reprogramming: transcription factors and transitions through mitosis.

Authors:  Dieter Egli; Garrett Birkhoff; Kevin Eggan
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07       Impact factor: 94.444

9.  Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells.

Authors:  Gang Chang; Yi-Liang Miao; Yu Zhang; Sheng Liu; Zhaohui Kou; Junjun Ding; Da-Yuan Chen; Qing-Yuan Sun; Shaorong Gao
Journal:  PLoS One       Date:  2010-04-26       Impact factor: 3.240

10.  Identification of inappropriately reprogrammed genes by large-scale transcriptome analysis of individual cloned mouse blastocysts.

Authors:  Atsushi Fukuda; Feng Cao; Shinnosuke Morita; Kaori Yamada; Yuko Jincho; Shouji Tane; Yusuke Sotomaru; Tomohiro Kono
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.